bg
A

Alimera Sciences (ALIM)

$000.00 0.00% ($0.00)

  • Today
  • Week
  • Month
  • Year
  • 5 Year
  • YTD
barakagetbaraka.com

About Alimera Sciences (ALIM)

Alimera Sciences, Inc. is a commercial-stage global pharmaceutical company. The Company is engaged in developing and commercializing ILUVIEN for the treatment of diabetic macular edema (DME), a cause of blindness, and outside the United States for no... Read more

  • USD3.36
  • USD3.36
  • USD3.18
  • USD4.38
  • -9.90%
  • 81M
  • 43.49k
  • 51.07k
  • 186M
  • 2.27
  • 55.30%

Unlock More Stock Analysis & Reports

Access detailed stock analysis from LSEG including analyst price target estimates.